Skip to content

Feasibility of an Automated Bidet Intervention to Decrease Caregiver Burden

Evaluating the Feasibility of an Automated Bidet Intervention to Decrease Caregiver Burden

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04283123
Enrollment
10
Registered
2020-02-25
Start date
2016-12-01
Completion date
2017-06-30
Last updated
2025-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caregiver Burnout

Keywords

Assistive Technology, Informal Caregivers, Occupational Therapy, Toileting

Brief summary

This study evaluates the feasibility, including acceptability and preliminary efficacy, of an automated bidet intervention to make it easier for caregivers to assist with toileting.

Detailed description

Informal caregivers provide over 30 billion hours of care to older adults each year. They often assist with toileting tasks which are often identified as one of the most physically and emotionally demanding activities of daily living. Caregivers receive limited training and support which increases their risk for injury and burnout. One potential strategy to reduce or replace the physical support needed from a caregiver is the used of an automated bidet system. It remains unknown whether an automated bidet can be used successfully with older adults and their caregivers at home. The objective of this feasibility study was to assess the acceptability and preliminary efficacy of a toileting intervention using an automated bidet system and training by an occupational therapy practitioner (OT) to reduce the amount of physical assistance required from caregivers. The investigators will recruit 10 informal caregivers and randomize them to the treatment or waitlist control group. Caregivers in the treatment group will receive the automated bidet right away while those in the waitlist control group will not receive any treatment during that time. After 30 days, both groups will participate in a post-test assessment visit. The waitlist control group will then be offered the intervention and invited to participate in a final session after 30 days to complete assessments and a process evaluation (30 days post follow-up).

Interventions

BEHAVIORALAutomated Bidet

During the first intervention visit, a licensed contractor will install the bidets in participants' homes. The OT will then educate and train the caregiver and care recipient to successfully use the bidet, and make any modifications to the remote as needed. Throughout the intervention, the OT will use motivational enhancement strategies. The OT will make minor modifications to the remote as needed. A second intervention visit will occur 1-2 weeks post-installation to address any new difficulties. Check-in phone calls will be offered to the caregiver and care recipient if needed.

OTHERNo Intervention

Waitlist control

Sponsors

Washington University School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* (1) provided unpaid care and lived with a care recipient aged 55 years or older * (2) assisted with toileting for at least 6 months * (3) did not have an automated bidet * (4) had a working toilet and bathroom outlet, and (5) their care recipient was willing to participate

Exclusion criteria

* Caregivers scoring 10 or above on the Short Blessed Test, indicating possible cognitive impairment

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants Recruited5 monthsThe ability to recruit 10 caregivers who were eligible for the study was used with other variables to assess feasibility
Number of Caregivers RetainedAt study completion (2 months [treatment] or 3 months [waitlist control])Retain 10 caregivers was used with other variables to assess feasibility
Number of Participants With Ability to Install the Automated Bidets, Including Any Modifications Needed30 days post-installationInstallation of the automated bidets and a record of any modifications needed was used with other variables to assess feasibility
Number of Caregivers' or Care Recipients' Who Can Operate the Bidet30 days post-installationDemonstrate ability to operate the bidet successfully which was used with other variables to assess feasibility
Acceptability30 days post-installation8-item process evaluation: rated on a scale of 0 (strongly disagree) to 4 (strongly agree) with higher scores indicating greater acceptance of the intervention
Preliminary Efficacy: Performance2 months (treatment) or 3 months (waitlist control)In-Home Occupational Performance Evaluation for Providing Assistance impact on caregiver outcomes rated on a scale of 1 to 5 with higher scores indicating better performance was used with other variables to assess feasibility
Preliminary Efficacy: Satisfaction2 months (treatment) or 3 months (waitlist control)In-Home Occupational Performance Evaluation for Providing Assistance: impact on caregiver outcomes rated on a scale of 1 to 5 with higher scores indicating better satisfaction was used with other variables to assess feasibility
Preliminary Efficacy: Self-efficacy2 months (treatment) or 3 months (waitlist control)In-Home Occupational Performance Evaluation for Providing Assistance: impact on caregiver outcomes rated on a scale of 1 to 5 with higher scores indicating better self-efficacy was used with other variables to assess feasibility
Preliminary Efficacy: Physical Environmental Barriers2 months (treatment) or 3 months (waitlist control)In-Home Occupational Performance Evaluation for Providing Assistance: reduction of physical barriers to toileting (rated on a scale from 0 (independent) to 5 (no activity/dependent) was used with other variables to assess feasibility
Adverse EventsAt study completion (2 months [treatment] or 3 months [waitlist control])Number of adverse events was used with other variables to assess feasibility

Participant flow

Pre-assignment details

We contacted 55 informal caregivers from December 2016 to April 2017. Twenty-four(43.6%) expressed interest in participating, but 14 were ineligible (7 did not provide toileting assistance; 3 primarily used a commode or absorbent underwear; 2 had paid caregivers; 1did not meet the age criterion; and 1 care recipient was interested, but the caregiver was not). Ten informal caregivers were enrolled in this study.

Participants by arm

ArmCount
Treatment
Participants assigned to this group will receive an automated bidet (TOTO Washlet S300e with remote control) and an occupational therapy intervention over 3-4 in-home visits. Automated Bidet: During the first intervention visit, a licensed contractor will install the bidets in participants' homes. The OT will then educate and train the caregiver and care recipient to successfully use the bidet, and make any modifications to the remote as needed. Throughout the intervention, the OT will use motivational enhancement strategies. The OT will make minor modifications to the remote as needed. A second intervention visit will occur 1-2 weeks post-installation to address any new difficulties. Check-in phone calls will be offered to the caregiver and care recipient if needed.
5
Waitlist Control
Caregivers will wait for 30 days and then will be offered the intervention. No Intervention: Waitlist control
5
Total10

Baseline characteristics

CharacteristicTreatmentTotalWaitlist Control
Age, Continuous68.40 years
STANDARD_DEVIATION 10.29
66.40 years
STANDARD_DEVIATION 11.87
64.40 years
STANDARD_DEVIATION 14.19
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants2 Participants2 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
5 Participants8 Participants3 Participants
Region of Enrollment
United States
5 participants10 participants5 participants
Sex: Female, Male
Female
3 Participants7 Participants4 Participants
Sex: Female, Male
Male
2 Participants3 Participants1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 50 / 5
other
Total, other adverse events
0 / 50 / 5
serious
Total, serious adverse events
0 / 50 / 5

Outcome results

Primary

Acceptability

8-item process evaluation: rated on a scale of 0 (strongly disagree) to 4 (strongly agree) with higher scores indicating greater acceptance of the intervention

Time frame: 30 days post-installation

ArmMeasureGroupValue (MEAN)Dispersion
TreatmentAcceptabilityThe automated bidet system was aesthetically pleasing/looked nice.3.60 units on a scaleStandard Deviation 0.55
TreatmentAcceptabilityThe automated bidet system was easy to use3.60 units on a scaleStandard Deviation 0.55
TreatmentAcceptabilityThe education and training on using the automated bidet system was very helpful4.00 units on a scaleStandard Deviation 0
TreatmentAcceptabilityThe automated bidet system made it easier for me to help my loved one with toileting3.80 units on a scaleStandard Deviation 0.45
TreatmentAcceptabilityI feel more confident assisting my loved one with toileting tasks3.20 units on a scaleStandard Deviation 0.84
TreatmentAcceptabilityThe automated bidet addressed my concerns for providing assistance with toileting in the home3.20 units on a scaleStandard Deviation 0.45
TreatmentAcceptabilityWe will continue to use the automated bidet system after the conclusion of the study4.00 units on a scaleStandard Deviation 0
TreatmentAcceptabilityThe presence of my loved one during study visits impacted my ability to answer questions truthfully3.40 units on a scaleStandard Deviation 1.34
Waitlist ControlAcceptabilityThe education and training on using the automated bidet system was very helpful4.00 units on a scaleStandard Deviation 0
Waitlist ControlAcceptabilityWe will continue to use the automated bidet system after the conclusion of the study4.00 units on a scaleStandard Deviation 0
Waitlist ControlAcceptabilityThe automated bidet system made it easier for me to help my loved one with toileting3.80 units on a scaleStandard Deviation 0.45
Waitlist ControlAcceptabilityI feel more confident assisting my loved one with toileting tasks3.80 units on a scaleStandard Deviation 0.45
Waitlist ControlAcceptabilityThe automated bidet addressed my concerns for providing assistance with toileting in the home3.60 units on a scaleStandard Deviation 0.55
Waitlist ControlAcceptabilityThe automated bidet system was aesthetically pleasing/looked nice.4.00 units on a scaleStandard Deviation 0
Waitlist ControlAcceptabilityThe automated bidet system was easy to use4.00 units on a scaleStandard Deviation 0
Waitlist ControlAcceptabilityThe presence of my loved one during study visits impacted my ability to answer questions truthfully4.00 units on a scaleStandard Deviation 0
TotalAcceptabilityThe education and training on using the automated bidet system was very helpful4.00 units on a scaleStandard Deviation 0
TotalAcceptabilityThe automated bidet system was easy to use3.80 units on a scaleStandard Deviation 0.42
TotalAcceptabilityThe automated bidet system was aesthetically pleasing/looked nice.3.80 units on a scaleStandard Deviation 0.42
TotalAcceptabilityThe automated bidet system made it easier for me to help my loved one with toileting3.80 units on a scaleStandard Deviation 0.42
TotalAcceptabilityWe will continue to use the automated bidet system after the conclusion of the study4.00 units on a scaleStandard Deviation 0
TotalAcceptabilityThe automated bidet addressed my concerns for providing assistance with toileting in the home3.40 units on a scaleStandard Deviation 0.52
TotalAcceptabilityI feel more confident assisting my loved one with toileting tasks3.50 units on a scaleStandard Deviation 0.71
TotalAcceptabilityThe presence of my loved one during study visits impacted my ability to answer questions truthfully3.70 units on a scaleStandard Deviation 0.95
Primary

Adverse Events

Number of adverse events was used with other variables to assess feasibility

Time frame: At study completion (2 months [treatment] or 3 months [waitlist control])

ArmMeasureValue (NUMBER)
TreatmentAdverse Events0 adverse events
Waitlist ControlAdverse Events0 adverse events
Primary

Number of Caregivers' or Care Recipients' Who Can Operate the Bidet

Demonstrate ability to operate the bidet successfully which was used with other variables to assess feasibility

Time frame: 30 days post-installation

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
TreatmentNumber of Caregivers' or Care Recipients' Who Can Operate the Bidet5 Participants
Waitlist ControlNumber of Caregivers' or Care Recipients' Who Can Operate the Bidet5 Participants
Primary

Number of Caregivers Retained

Retain 10 caregivers was used with other variables to assess feasibility

Time frame: At study completion (2 months [treatment] or 3 months [waitlist control])

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
TreatmentNumber of Caregivers Retained5 Participants
Waitlist ControlNumber of Caregivers Retained5 Participants
Primary

Number of Participants Recruited

The ability to recruit 10 caregivers who were eligible for the study was used with other variables to assess feasibility

Time frame: 5 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
TreatmentNumber of Participants Recruited5 Participants
Waitlist ControlNumber of Participants Recruited5 Participants
Primary

Number of Participants With Ability to Install the Automated Bidets, Including Any Modifications Needed

Installation of the automated bidets and a record of any modifications needed was used with other variables to assess feasibility

Time frame: 30 days post-installation

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
TreatmentNumber of Participants With Ability to Install the Automated Bidets, Including Any Modifications Needed5 Participants
Waitlist ControlNumber of Participants With Ability to Install the Automated Bidets, Including Any Modifications Needed5 Participants
Primary

Preliminary Efficacy: Performance

In-Home Occupational Performance Evaluation for Providing Assistance impact on caregiver outcomes rated on a scale of 1 to 5 with higher scores indicating better performance was used with other variables to assess feasibility

Time frame: 2 months (treatment) or 3 months (waitlist control)

Population: The I-HOPE Assist was completed with caregivers at pretest and posttest (30 days post-intervention for the treatment group or 30 days post-enrollment for the control group), and at follow-up for the waitlist control group (30 days post-installation).

ArmMeasureGroupValue (MEAN)Dispersion
TreatmentPreliminary Efficacy: PerformancePretest3.20 units on a scaleStandard Deviation 1.3
TreatmentPreliminary Efficacy: PerformancePosttest4.20 units on a scaleStandard Deviation 0.45
Waitlist ControlPreliminary Efficacy: PerformancePretest4.20 units on a scaleStandard Deviation 0.84
Waitlist ControlPreliminary Efficacy: PerformancePosttest3.40 units on a scaleStandard Deviation 0.89
Waitlist ControlPreliminary Efficacy: PerformanceFollow-up4.40 units on a scaleStandard Deviation 0.55
Primary

Preliminary Efficacy: Physical Environmental Barriers

In-Home Occupational Performance Evaluation for Providing Assistance: reduction of physical barriers to toileting (rated on a scale from 0 (independent) to 5 (no activity/dependent) was used with other variables to assess feasibility

Time frame: 2 months (treatment) or 3 months (waitlist control)

Population: The I-HOPE Assist was completed with caregivers at pretest and posttest (30 days post-intervention for the treatment group or 30 days post-enrollment for the control group), and at follow-up for the waitlist control group (30 days post-installation).

ArmMeasureGroupValue (MEAN)Dispersion
TreatmentPreliminary Efficacy: Physical Environmental BarriersPretest10.20 units on a scaleStandard Deviation 3.7
TreatmentPreliminary Efficacy: Physical Environmental BarriersPosttest8.20 units on a scaleStandard Deviation 3.11
Waitlist ControlPreliminary Efficacy: Physical Environmental BarriersPosttest8.60 units on a scaleStandard Deviation 3.36
Waitlist ControlPreliminary Efficacy: Physical Environmental BarriersPretest9.00 units on a scaleStandard Deviation 3.39
Waitlist ControlPreliminary Efficacy: Physical Environmental BarriersFollow-up6.40 units on a scaleStandard Deviation 2.7
TotalPreliminary Efficacy: Physical Environmental BarriersPosttest8.40 units on a scaleStandard Deviation 3.06
TotalPreliminary Efficacy: Physical Environmental BarriersFollow-up6.40 units on a scaleStandard Deviation 2.7
TotalPreliminary Efficacy: Physical Environmental BarriersPretest9.60 units on a scaleStandard Deviation 3.41
Primary

Preliminary Efficacy: Satisfaction

In-Home Occupational Performance Evaluation for Providing Assistance: impact on caregiver outcomes rated on a scale of 1 to 5 with higher scores indicating better satisfaction was used with other variables to assess feasibility

Time frame: 2 months (treatment) or 3 months (waitlist control)

Population: The I-HOPE Assist was completed with caregivers at pretest and posttest (30 days post-intervention for the treatment group or 30 days post-enrollment for the control group), and at follow-up for the waitlist control group (30 days post-installation).

ArmMeasureGroupValue (MEAN)Dispersion
TreatmentPreliminary Efficacy: SatisfactionPretest3.20 units on a scaleStandard Deviation 1.48
TreatmentPreliminary Efficacy: SatisfactionPosttest4.40 units on a scaleStandard Deviation 0.55
Waitlist ControlPreliminary Efficacy: SatisfactionPretest3.40 units on a scaleStandard Deviation 1.14
Waitlist ControlPreliminary Efficacy: SatisfactionPosttest3.00 units on a scaleStandard Deviation 0.71
Waitlist ControlPreliminary Efficacy: SatisfactionFollow-up4.60 units on a scaleStandard Deviation 0.55
Primary

Preliminary Efficacy: Self-efficacy

In-Home Occupational Performance Evaluation for Providing Assistance: impact on caregiver outcomes rated on a scale of 1 to 5 with higher scores indicating better self-efficacy was used with other variables to assess feasibility

Time frame: 2 months (treatment) or 3 months (waitlist control)

Population: The I-HOPE Assist was completed with caregivers at pretest and posttest (30 days post-intervention for the treatment group or 30 days post-enrollment for the control group), and at follow-up for the waitlist control group (30 days post-installation).

ArmMeasureGroupValue (MEAN)Dispersion
TreatmentPreliminary Efficacy: Self-efficacyPretest3.20 units on a scaleStandard Deviation 1.3
TreatmentPreliminary Efficacy: Self-efficacyPosttest4.60 units on a scaleStandard Deviation 0.55
Waitlist ControlPreliminary Efficacy: Self-efficacyPosttest3.60 units on a scaleStandard Deviation 0.55
Waitlist ControlPreliminary Efficacy: Self-efficacyFollow-up4.80 units on a scaleStandard Deviation 0.45
Waitlist ControlPreliminary Efficacy: Self-efficacyPretest3.60 units on a scaleStandard Deviation 1.52

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026